Murdoch University Research Repository

Welcome to the Murdoch University Research Repository

The Murdoch University Research Repository is an open access digital collection of research
created by Murdoch University staff, researchers and postgraduate students.

Learn more

The Staphylococcus aureus Network Adaptive Platform Trial Protocol: New Tools for an Old Foe

Tong, S.Y.C., Mora, J., Bowen, A.C., Cheng, M.P., Daneman, N., Goodman, A.L., Heriot, G.S., Lee, T.C., Lewis, R.J., Lye, D.C., Mahar, R.K., Marsh, J., McGlothlin, A., McQuilten, Z., Morpeth, S.C., Paterson, D.L., Price, D.J., Roberts, J.A., Robinson, J.O., van Hal, S.J., Walls, G., Webb, S.A., Whiteway, L., Yahav, D., Davis, J.S., Anagnostou, N., Archuleta, S., Athan, E., Best, E., Bloomfield, M., Botheras, C., Bowen, A., Britton, P., Brown, K., Campbell, A., Carter, H., Cheng, M., Chew, K.L., Chong, R.L.M., Coombs, G., Daley, P., Daneman, N., Davies, J., Davis, J., Dishon, Y., Dotel, R., Dunlop, A., Flack, F., Flanagan, K., Foo, H., Ghanem-Zoubi, N., Giulieri, S., Goodman, A., Grant, J., Gregson, D., Guy, S., Gwee, A., Hardy, E., Henderson, A., Heriot, G., Howden, B., Johnstone, J., Kalimuddin, S., de Kretser, D., Kwa, A., Lee, T., Legg, A., Lewis, R., Lumley, T., Lye, D., MacFadden, D., Mahar, R., Malhamé, I., Marks, M., Marsh, J., Martinello, M., Matthews, G., McArthur, C., McGlothlin, A., McKew, G., McMullan, B., McQuilten, Z., Milliken, E., Mora, J., Morpeth, S., Murthy, S., Nourse, C., O’Sullivan, M., Paterson, D., Paul, M., Petersiel, N., Petrella, L., Price, D., Roberts, J., Rogers, B., Saville, B., Scheetz, M., Scheuerman, O., Schwartz, K., Smith, S., Snelling, T., Sommerville, C., Stewardson, A., Sud, A., Tong, S., Turner, T., van Hal, S., Vasilunas, N., Voss, L., Walls, G., Webb, R., Webb, S., Whiteway, L., Wilson, H., Wuerz, T. and Yahav, D. (2022) The Staphylococcus aureus Network Adaptive Platform Trial Protocol: New Tools for an Old Foe. Clinical Infectious Diseases .

Link to Published Version: https://doi.org/10.1093/cid/ciac476
*Subscription may be required

Abstract

Staphylococcus aureus bloodstream (SAB) infection is a common and severe infectious disease, with a 90-day mortality of 15%–30%. Despite this, <3000 people have been randomized into clinical trials of treatments for SAB infection. The limited evidence base partly results from clinical trials for SAB infections being difficult to complete at scale using traditional clinical trial methods. Here we provide the rationale and framework for an adaptive platform trial applied to SAB infections. We detail the design features of the Staphylococcus aureus Network Adaptive Platform (SNAP) trial that will enable multiple questions to be answered as efficiently as possible. The SNAP trial commenced enrolling patients across multiple countries in 2022 with an estimated target sample size of 7000 participants. This approach may serve as an exemplar to increase efficiency of clinical trials for other infectious disease syndromes.

Item Type: Journal Article
Publisher: Oxford University Press on behalf of Infectious Diseases Society of America
Copyright: © 2022 The Authors.
Notes: ...for the Staphylococcus aureus Network Adaptive Platform (SNAP) Study Group
URI: http://researchrepository.murdoch.edu.au/id/eprint/65475
Item Control Page Item Control Page